Filter
4951
Filtered Results: 4951
Text search:
global
burden
of
disease
Featured
Recommendations
400
New Publications
1161
Language
Document type
No document type
2522
Studies & Reports
1208
Guidelines
543
Strategic & Response Plan
241
Manuals
207
Fact sheets
98
Training Material
54
Situation Updates
24
Resource Platforms
20
Infographics
19
Dashboards/Maps
5
Brochures
4
Online Courses
4
Videos
2
Countries / Regions
Global
361
India
176
Kenya
151
Western and Central Europe
120
South Africa
107
Ethiopia
101
Africa
96
Latin America and the Carribbean
91
Nigeria
84
Uganda
79
Sierra Leone
71
Liberia
64
Nepal
62
Zambia
62
Malawi
62
Tanzania
60
Ghana
57
Eastern Europe
57
Bangladesh
56
Ukraine
56
Rwanda
52
Myanmar / Burma
47
South–East Asia Region
45
Asia
45
Namibia
43
Syria
41
Philippines
35
Russia
31
Mozambique
30
Zimbabwe
29
South Sudan
28
Cambodia
28
East and Southern Africa
28
Brazil
27
Lesotho
27
Congo, Democratic Republic of
25
Indonesia
25
West and Central Africa
25
Senegal
19
Guinea
18
Botswana
18
Pakistan
17
Eastern Europe and Central Asia
17
Haiti
15
Burkina Faso
14
Cameroon
14
Germany
14
Eswatini/ Swaziland
14
Sudan
13
Middle East and North Africa
13
Yemen
12
Western Pacific Region
12
Afghanistan
10
Thailand
10
Colombia
10
Venezuela
10
North America
10
Somalia
9
Benin
8
Chile
8
Albania
8
Tajikistan
8
Vietnam
8
USA
7
Jordan
7
Central African Republic
7
Peru
7
Moldova
7
Iraq
6
Lebanon
6
Argentina
6
Ecuador
6
Mali
5
North Macedonia
5
Madagascar
5
Sri Lanka
5
Laos
5
Iran
5
Georgia
5
Saudi Arabia
4
Turkey
4
Egypt
4
China
4
Burundi
4
Libya
4
Paraguay
4
Palestine
4
Armenia
4
Southern Africa
4
Jamaica
4
Angola
3
Mexico
3
Timor Leste/ East Timor
3
Romania
3
Kyrgyzstan
3
Turkmenistan
3
Mauritius
3
Belarus
3
Papua New Guinea
2
Greece
2
Other region
2
Bhutan
2
Poland
2
Djibouti
2
Qatar
2
Kazakhstan
2
Gabon
2
United Kingdom
2
Bosnia and Herzegovina
2
Guinea-Bissau
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Niger
1
Chad
1
Gambia
1
Ireland
1
Hungary
1
Honduras
1
El Salvador
1
Bolivia
1
Guatemala
1
North Korea
1
Mongolia
1
Canada
1
Bulgaria
1
Estonia
1
Slovakia
1
Japan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Tunisia
1
Portugal
1
Spain
1
Azerbaijan
1
Barbados
1
Authors & Publishers
Publication Years
Category
Countries
1673
Clinical Guidelines
464
Public Health
451
Women & Child Health
197
Key Resources
156
Capacity Building
57
Pharmacy & Technologies
33
Annual Report MEDBOX
2
Toolboxes
TB
457
HIV
439
Mental Health
389
COVID-19
349
Planetary Health
258
NCDs
249
AMR
210
NTDs
187
Global Health Education
130
Disability
124
Caregiver
110
Rapid Response
106
Conflict
97
Health Financing Toolbox
76
Ebola
58
Refugee
55
Pharmacy
48
Polio
28
Natural Hazards
27
Cholera
26
Social Ethics
13
Zika
12
Specific Hazards
8
South Sudan
1
Health Financing
1
Spread of resistance to antimicrobial agents (AMR) does not know national borders and has reached dimensions, which require immediate actions at the national, regional and global levels.
Antibiotic...
No education system is effective unless it promotes the health and well-being of its students, staff and community. These strong links have never been more visible and compelling than in the context of...
Climate change has important implications for the health and futures of children and young people, yet they have little power to limit its harm, making them vulnerable to climate anxiety. This is the first large-scale investigation ... climate anxiety in children and young people globally and its relationship with perceived government response.
As the Group of Eight (G8) world leaders meet in Saint Petersburg, Russia for this year’s G8 Summit, it is important to take stock of international efforts to finance the response to the ... HIV/AIDS epidemic. Financing a sufficient and sustained response to the epidemic has emerged as one of the world’s greatest challenges, and one that will be with us for the foreseeable future. Often, those countries most affected are also least able to respond, increasing their vulnerability to HIV/AIDS and in turn further complicating their ability to address the epidemic, as is the case for many nations in sub-Saharan Africa. In addition, concerns have been raised about “second wave” nations, particularly China, India, and Russia, which stand on the brink of generalized epidemics if more is not done now
This version of Field Trials of Health Interventions includes seven new chapters on conducting systematic literature reviews, trial
governance, preliminary studies and pilot testing, budgeting and ...
NEUROLOGY ATLAS presents for the first time, the most
comprehensive collection and compilation of information on
neurological resources across 109 countries. The results confirm
that the available resources including services for neurological
di...
Peru celebrates 200 years of independence in 2021. Over this period of independent life, and despite the turbulent socio-political scenarios, from internal armed conflict to economic crisis to polit...
Download (7.4 MB)
Overview
Epilepsy is one of the most common neurological disorders globally. The WHO epilepsy technical brief aims to strengthen action for epilepsy and complements the Intersectoral gl... action plan on epilepsy and other neurological disorders 2022–2031.
The technical brief presents the key information on epilepsy and recommends actions to policy makers and other stakeholders. Using the concept of levers for change introduced by the Operational Framework for Primary Health Care, it identifies actions on the policy and operational levels that stakeholders should take to strengthen services for people with epilepsy using a person-centered approach based on human rights and universal health coverage.
The increasing amounts of official development assistance (ODA) for health have been aimed primarily at fighting HIV/AIDS, malaria and tuberculosis. Neglected tropical diseases (NTD), one ... the most serious public health burdens among the most deprived communities, have only recently drawn the attention of major donors. While frequently stated, the low share
of funding for NTD control projects has not been calculated empirically. Our analysis of ODA commitments for infectious disease control for the years 2003 to 2007 confirms that Development Assistance Committee (DAC)-countries and multilateral donors have largely ignored funding NTD control projects. On average, only 0.6% of total annual health ODA was dedicated
to the fight against NTDs while the average share of control projects for HIV/AIDS was 36.3%, for malaria 3.6%, and for tuberculosis 2.2%. This allocation of health ODA does not reflect the diseases’ respective health burdens.
Technical Update
Areas of Africa endemic for Buruli ulcer (BU), caused by Mycobacterium ulcerans, also have a high prevalence of human immunodeficiency virus (HIV), with adult prevalence rates betw...
Procurement and supply management activities are fundamental to consistent and reliable access to essential medicines and health products. To reduce the impact of CVD, action needs to be taken to improve prevention, diagnosis, care and management ... CVD diseases. Affordable essential medicines and technologies to manage CVD disease must be available where and when they are required. Medicines and technologies need to be managed appropriately to ensure that the correct medicines are selected, procured in the right quantities, distributed to facilities in a timely manner, and handled and stored in a way that maintains their quality. This needs to be backed up by policies that enable sufficient quantities to be procured in order to reduce cost inefficiencies, ensure the reliability and security of the distribution system, and encourage the appropriate use of these health products. In order to avoid stock-outs and the disruption of treatment, all related activities need to be conducted in a timely manner, with performance continually monitored, and prompt action taken in response to problems that may arise. Additionally, medication must be dispensed correctly and used rationally by the healthcare provider and patient alike. The purpose of this guide is to explain the necessary steps.
Antimalarial drug resistance has emerged as a threat to global malaria control efforts, particularly in the Greater Mekong subregion. Drawing on data collected through more than 1000 therapeutic efficacy studies as well as molecular marker studies <... Plasmodium falciparum drug resistance, the Report on antimalarial drug efficacy, resistance and response: 10 years of surveillance (2010–2019) presents a decade’s worth of data on drug efficacy and surveillance, as well as recommendations to monitor and protect the efficacy of malaria treatment in the decades to come.
To support countries in adapting their response to different COVID-19 scenarios, the World Health
Organization (WHO) Department of Maternal, Newborn, Child and Adolescent Health and Ageing commissioned this scoping review ... published and grey literature. The objective was to identify interventions implemented to maintain the provision and use of essential services for MNCAAH during disruptive events and to summarize lessons learned during these interventions. The review included outbreaks of Ebola virus disease (EVD), severe acute respiratory syndrome (SARS), Zika virus disease (ZVD), the ongoing COVID-19 pandemic, and natural disasters and humanitarian emergencies that caused disruption to services, transport and other activities.
Schistosomiasis is a helminthic infection and one of the neglected tropical diseases (NTDs). It is caused by blood flukes of the genus Schistosoma....
Today, the World Health Organization (WHO) is advancing the global fight against acute malnutrition in children under 5 with the launch of its new guideline on the prevention and management ... wasting and nutritional oedema (acute malnutrition). This milestone is a crucial response to the persistent global issue of acute malnutrition, which affects millions of children worldwide.
In 2015, the world committed to achieving the Sustainable Development Goals (SDGs), including the ambitious target of eliminating malnutrition in all of its forms by 2030. However, despite these commitments, the proportion of children with acute malnutrition has persisted at a worrying level, affecting an estimated 45 million children under five worldwide in 2022.
In 2022, approximately 7.3 million children received treatment for severe acute malnutrition (SAM). Although treatment coverage has increased, children with SAM in many of the worst affected countries are still unable to access the full necessary care for them to recover.
The Global Action Plan (GAP) on child wasting recognized the need for updated normative guidance to support governments in the prevention and management of acute malnutrition. WHO answered this call to action and developed a comprehensive guideline that provides evidence-based recommendations and good practice statements and will be followed by guidance and tools for implementation.
Hypertension is referred to as a “silent killer”. Most people with hypertension are unaware of their condition as in most cases, they experience no warning signs or symptoms hence they are not identified or treated. Hypertention is associated wi...
The pharmacological management of asthma has changed considerably in recent decades, as it has come to be understood that it is a complex, heterogeneous disease with different phenotypes and endotyp...
This publication is based on the list of clinical interventions selected from clinical guidelines on prevention, screening, diagnosis, treatment, palliative care, monitoring and end of life care. Th...
Latin America and the Caribbean is characterized by a matrix of social inequality whose axes —such as
socioeconomic stratum, gender, stage in the life cycle, ethnicity and race, territory, disability, and immigration
status— create multiple, o...
Atlas of African Health Statistics 2022: Health situation analysis of the WHO African Region
Since 2019, we have been implementing Phase 2 of the ...
